氢分子医学分享 http://blog.sciencenet.cn/u/孙学军 对氢气生物学效应感兴趣者。可合作研究:sunxjk@hotmail.com 微信 hydrogen_thinker

博文

氢气和一氧化碳结合用于体外器官保护是最佳搭配

已有 7944 次阅读 2009-2-18 14:57 |个人分类:呼吸氢气|系统分类:科研笔记| 论文, 氢气, 氢分子医学

这个没有摘要和全文,只有题目. 有具体内容后再修改. 这说明有人在进行这方面的探讨.值得注意

Copyright © 2009 International Society for Heart and Lung Transplantation Published by Elsevier Inc.

Abstract

135: Combined Administration of Hydrogennext term Gas and Carbon Monoxide Is a Superior Strategy for Ameliorating Cardiac Cold Ischemia/Reperfusion Injury in previous termRatsnext term

A. Nakao*, a, D.J. Kaczorowskia, R. Sugimotoa, J. Zhana, Y. Wanga and K.R. McCurrya

aHeart, Lung and Esophageal Surgery Institute, University of Pittsburgh, Pittsburgh, PA

 

COMBINED ADMINISTRATION OF HYDROGEN AND CARBON MONOXIDE IS A SUPERIOR STRATEGY FOR AMELIORATIONG CARDIAC Cold Ischemia/Reperfusion Injury

 

Atsunori Nakao, David J Kaczorowski, Ryujiro Sugimoto, Jianghua Zhan, Yinna Wang, Kenneth R McCurry

 

Thomas E Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh

Department of Surgery, University of Pittsburgh

 

Background: Hydroxyl radicals, generated during ischemia/reperfusion injury (IRI), play a critical role in graft injury. Recently, it has been reported that hydrogen (H2) gas alleviates oxidative injury by selectively neutralizing hydroxyl radicals. In this study, we evaluated the combined effects of H2 with carbon monoxide (CO), a molecule known to have anti-inflammatory and anti-apoptotic properties.  

Methods: Syngeneic, heterotopic HTx (LEW rats) was performed with 18 hrs of cold ischemia time. In the H2 or CO treated group, both donor and recipients were treated with H2 (2%) or CO (250 ppm) in air 1 hr before and 1 hr after reperfusion.

Results: In control (air) recipients, serum troponin I (TnI) and CPK levels increased within 3 hrs, but were significantly attenuated with H2 treatment. Cardiomyocyte apoptosis, prevalent in control grafts at 6 hrs, was also significantly attenuated with H2.  H2 treatment resulted in significantly reduced MDA levels after transplant, demonstrating attenuated lipid peroxidation, and also reduced serum high-mobility group box-1 (HMGB1) levels. CO had marginal effects on preventing lipid peroxidation and myocardial oxidative injury. However, CO suppressed inflammatory responses, reducing graft mRNA levels for TNFα and serum IL-6, whereas H2 did not. These results suggest that H2 does not possess direct anti-inflammatory effects, but CO does. Conversely, while H2 has potent anti-oxidant properties, CO has marginal effects in scavenging radicals. Dual therapy with CO and H2 demonstrated both anti-oxidant and anti-inflammatory effects.  

Conclusion: Mixed gas therapy with CO and H2 is a novel, safe and potent approach for preventing cardiac cold IRI.

Table. The effects of CO and hydrogen for cardiac cold I/R injury (*p<0.05 vs HTx/air)

 

TnI (3h)

CPK (IU/L, 3h)

TUNEL (6h)

MDA (3h)

HMGB1 (1h)

Serum IL-6 (3h)

normal

1.1

101

7.4

0.47

0.08

21

HTx (air)

224.7

15312

55.4

0.85

4.3

928.1

HTx (CO)

160.3

9171

35.2

0.83

3.8

462*

HTx (H2)

80.5*

5458*

24.3*

0.65*

2.6

872.1

HTx (CO/H2)

47.5*

4405*

22.1*

0.59*

2.7

206.4*

 

 

 

具体内容可以参考其一综述:

J Clin Biochem Nutr. 2009 Jan;44(1):1-13. Epub 2008 Dec 27.Click here to read Links

Therapeutic antioxidant medical gas.

Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.

Medical gases are pharmaceutical gaseous molecules which offer solutions to medical needs and include traditional gases, such as oxygen and nitrous oxide, as well as gases with recently discovered roles as biological messenger molecules, such as carbon monoxide, nitric oxide and hydrogen sulphide. Medical gas therapy is a relatively unexplored field of medicine; however, a recent increasing in the number of publications on medical gas therapies clearly indicate that there are significant opportunities for use of gases as therapeutic tools for a variety of disease conditions. In this article, we review the recent advances in research on medical gases with antioxidant properties and discuss their clinical applications and therapeutic properties.

PMID: 19177183 [PubMed - in process]

PMCID: PMC2613492

 

 


Available online 24 January 2009.

Article Outline

Purpose
Methods and Materials
Results
Conclusions


https://wap.sciencenet.cn/blog-41174-215774.html

上一篇:氢气对巴金森氏病的治疗和预防作用
下一篇:氢气治疗小肠缺血引起的肺损伤
收藏 IP: .*| 热度|

2 唐小卿 zhangling

发表评论 评论 (0 个评论)

数据加载中...
扫一扫,分享此博文

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-11-1 07:22

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部